Phase II study of irinotecan in combination with capecitabine as a first-line chemotherapy in Asian patients with inoperable hepatocellular carcinoma

Tony S.K. Mok*, Tsai Shen Yang, Yee Chao, Cheng Hsu Wang, Mei Ching Liu, Yoon Koo Kang, Won Ki Kang, Jun Suk Kim, Yajie Wang, Thomas Leung

*Corresponding author for this work

Research output: Contribution to journal › Journal Article › peer-review

Fingerprint

Dive into the research topics of 'Phase II study of irinotecan in combination with capecitabine as a first-line chemotherapy in Asian patients with inoperable hepatocellular carcinoma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science